Curanex Pharmaceuticals Inc (CURX)
Curanex Pharmaceuticals Inc (NASDAQ-CURX) is a Healthcare sector company in the Pharmaceuticals industry. The Curanex Pharmaceuticals Inc security is listed on NASDAQ as common stock, so it should be viewed as common equity in a company rather than a fund or debt instrument. Based on the available business description, the company is associated with pharmaceutical research and development focused on botanical or plant-derived treatments for inflammatory and related medical conditions. This overview reflects the security context of the listing and does not add details beyond the supplied classification and company description.
Stock Summary
Fair Value
Profitability & Growth
Quality & Risk
Events & Dividends
Technical Outlook
FAQ
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-CURX
|
$0.30
|
44.4% Upside
|
Undervalued
|
—
|
—
|
—
|
Weak
|
—
|
—
|
—
|
0.0%
|
August 13, 2026
|
-0.8x
|
0.7x
|
—
|
5.716 M
|
2.249 M
|
5.2%
|
32.2%
|
7.2
|
—
|
156.0%
|
